Cidara shareholders OK doubling authorized shares to 100M and adding 2.88M shares to equity plan

Cidara Therapeutics, Inc.

Shareholders approved certificate amendment to increase authorized common shares from 50M to 100M, effective June 18, 2025.
2024 Equity Incentive Plan amended to increase share reserve by 2,880,000 shares; approved by stockholders.
Elected Jeffrey Stein, Bonnie Bassler, and Ryan Spencer as Class I directors for terms expiring at 2028 annual meeting.
Ratified Ernst & Young as independent auditor for FY2025; advisory say-on-pay passed.
Voting results: Charter amendment 13,042,275 for, 97,601 against; Equity plan 7,791,328 for, 3,033,052 against.

item 5.02item 5.03item 5.07item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.